RS-ibuprofen and S-ibuprofen (dexibuprofen) - Binary system and unusual solubility behaviour

被引:0
|
作者
Burger, A [1 ]
Koller, KT [1 ]
Schiermeier, WM [1 ]
机构
[1] UNIV INNSBRUCK, INST PHARMACOGNOSY, A-6020 INNSBRUCK, AUSTRIA
关键词
ibuprofen; dexibuprofen; solubility; liquid crystals; phase diagram; enantiomers; racemic compound;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The solubility C-s of S-(+)-ibuprofen (dexibuprofen, S-ibu) in aqueous HCI/KCl buffer solution, pH 1.5, is about twice that of RS-(+/-)-ibuprofen (rac-ibu) at 20 degrees C and 38 degrees C. Dependent on temperature T (K), the solubility C-s (mmol l(-1)) can be described by In C-s = - 433.45 + 16808.04 . T-1 + 66.02 . In T for S-ibu and by ln C-s = - 464.80 + 17594.54 . T-1 + 70.91 . ln T for rac-ibu. The difference in the heats of solution of S-ibu and rac-ibu aggrees with the difference in the heats of fusion. The solubility of S-ibu is 3.5 times more dependent on addition of polysorbate 80 than that of rac-ibu at 20 degrees C and pH 1.5. The solubility as a function of the pH follows the equation C-s = C-s,C-0.(1 + 10(pH-pK)a,2). At 20 degrees C, C-s,C-0(S-ibu) is 0.336 mmol l(-1) and C-s,C-0(rac-ibu) is 0.145 mmol l(-1); at 38 degrees C the values for C-s,C-0 are 0.622 mmol l(-1) and 0.306 mmol l(-1) (pK(a,2) = 4.430 at 20 and 38 degrees C). The analytical data deviate from theoretical data at pi-I-values higher than 6.5. Formation of liquid crystals (lyotropic mesophases) was discovered as a reason for this deviation. The binary phase diagram confirmed that rac-ibu (melting peak by DSC 74.8 degrees C, heat of fusion 25.7 kJ mol(-1), true density 1.110 g cm(-3)) is a racemic compound. The eutectic points (calculated) are at 49.6 degrees C and at 0.06 and 0.94 mole fractions of S-ibu (melting peak by DSC 51.2 degrees C, heat of fusion 18.7 kJ mol(-1), true density 1.093 g cm(-3)). Furthermore, an unstable phase can be found in the area near the eutectic, yet only in binary mixtures. Its formation is favoured by the low tendency of crystallization between 0.80 and 0.93 mole fractions of S-ibu. It was not possible to gain the corresponding unstable modification either of pure S-ibu or rac-ibu. The main reason is that the unstable phase again induces the crystallization of S-ibu and rac-ibu.
引用
收藏
页码:142 / 147
页数:6
相关论文
共 50 条
  • [1] Preliminary toxicokinetic study with different crystal forms of S (+)-ibuprofen (dexibuprofen) and R,S-ibuprofen in rats
    Walser, S
    Hruby, R
    Hesse, E
    Heinzl, H
    Mascher, H
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1997, 47 (06): : 750 - 754
  • [2] Pharmacokinetics (PK) of S-ibuprofen and racemic ibuprofen.
    Maenpaa, J
    Perttunen, K
    Ikavalko, H
    Hakola, P
    Seppanen, J
    Hanski, K
    Kleimola, T
    Aranko, K
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 63 (02) : 143 - 143
  • [3] STEREOSELECTIVE METABOLISM OF IBUPROFEN IN HUMANS - ADMINISTRATION OF R-IBUPROFEN, S-IBUPROFEN AND RACEMIC IBUPROFEN
    RUDY, AC
    KNIGHT, PM
    BRATER, DC
    HALL, SD
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1991, 259 (03): : 1133 - 1139
  • [4] ACTIVITY OF IBUPROFEN RACEMATE AND S-IBUPROFEN IN A CUTANEOUS MODEL OF INFLAMMATION
    GABARD, B
    BIELI, E
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 183 (06) : 2258 - 2259
  • [5] Chiral purification of S-ibuprofen from ibuprofen enantiomers by stripping crystallization
    Shiau, Lie-Ding
    Liu, Keng-Fu
    Hsu, Yu-Chao
    CHEMICAL ENGINEERING RESEARCH & DESIGN, 2017, 117 : 301 - 308
  • [6] Comparative Pharmacology of S(+)-Ibuprofen and (RS)-Ibuprofen
    A. M. Evans
    Clinical Rheumatology, 2001, 20 : 9 - 14
  • [7] Comparative pharmacology of s(+)-ibuprofen and (RS)-ibuprofen
    Evans, AM
    CLINICAL RHEUMATOLOGY, 2001, 20 (Suppl 1) : 9 - 14
  • [8] High-pressure study of R,S-ibuprofen
    Ostrowska, Kinga
    Kropidlowska, Magdalena
    Katrusiak, Andrzej
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2015, 71 : S369 - S369
  • [9] Solubility of (±)-ibuprofen and S (±)-ibuprofen in the presence of cosolvents and cyclodextrins
    Nerurkar, J
    Beach, JW
    Park, MO
    Jun, HW
    PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2005, 10 (03) : 413 - 421
  • [10] Enantioselective Toxicity of Ibuprofen to Earthworms: Unraveling the Effect and Mechanism on Enhanced Toxicity of S-Ibuprofen Over R-Ibuprofen
    Jiang, Wenqi
    Zhao, Zeyu
    Zhao, Qi
    He, Xiwei
    Chen, Haonan
    Wu, Gang
    Zhang, Xu-Xiang
    ENVIRONMENTAL SCIENCE & TECHNOLOGY, 2024, 59 (01) : 756 - 766